Inhibition of PI3K, the upstream activator of AKT, has been shown to sensitise various pancreatic cancer cell lines to the apoptotic effect of chemotherapy in vitro (Ng et al, 2000; Perugini et al, 2000; Yao et al, 2002). Here, AKT1 is linked to pancreatic neoplasm.